Tuesday, November 24, 2009, 3:21am EST - Canadian Markets open in 6 hours and 9 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Valeant Pharmaceuticals International (VRX)

 On Nov 23: 32.60 USD   0.00 (0.00%)  
MORE ON VRX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
VALEANT PHARMA INTL (NYSE:VRX) Delayed quote dataEdit
Last Trade: 32.60 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 32.60
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 24.57
Day's Range: N/A - N/A
52wk Range: 15.64 - 34.44
Volume: 0
Avg Vol (3m): 811,325
Market Cap: 2.65B
P/E (ttm): N/A
EPS (ttm): -0.64
Div & Yield: N/A (N/A%)
Valeant Pharmaceuticals International (VRX)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add VRX to Portfolio   Download Data

HEADLINES
• Valeant Pharma begins selling generic IBS drug
AP (Mon 3:46pm)
• [$$] Valeant Shares Fall Ill
at Barrons.com (Mon 2:03pm)
• Barron's Magazine First Read: Dividends, VRX, DISCA
at Barrons.com (Mon 10:00am)
• Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
PRNewswire (Mon 8:01am)
• Valeant may fall if new drug disappoints-Barron's
at Reuters (Sun, Nov 22)
• This Weekend's Barron's: Dividend Paying Stocks; BB&T Is the Banking Belle of the South; Is There Any Hope for Atlantic City
at Barrons.com (Sat, Nov 21)
• [$$] Hot Drug Stock in Need of a Chill Pill
at Barrons.com (Sat, Nov 21)
• Drugmaker Reinvents Itself And Expands Footprint Internationally
Investor's Business Daily (Wed, Nov 18)
• Big Value in Valeant
RealMoney by TheStreet.com (Wed, Nov 11)
• VALEANT PHARMACEUTICALS INTERNATIONAL Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal
EDGAR Online (Tue, Nov 10)
• UBS Research Equity Analyst Picks Top Stocks In Large Cap Biotech Sector
Wall Street Transcript (Tue, Nov 10)
More Headlines for VRX...
ANALYST
EPS Est (next year) (Dec-09) : 2.04
EPS Est (in 2 years) (Dec-10) : 2.27
Avg Rec (current)*: 3.6
PEG Ratio: 0.95
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices